Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
19.80
-1.60 (-7.48%)
At close: Mar 3, 2025, 4:00 PM
19.60
-0.20 (-1.01%)
Pre-market: Mar 4, 2025, 4:05 AM EST
Travere Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 58.54 | 58.18 | 61.69 | 165.75 | 84.77 | Upgrade
|
| Short-Term Investments | 312.17 | 508.68 | 388.56 | 387.13 | 276.82 | Upgrade
|
| Cash & Short-Term Investments | 370.7 | 566.85 | 450.25 | 552.88 | 361.59 | Upgrade
|
| Cash Growth | -34.60% | 25.90% | -18.56% | 52.90% | -9.27% | Upgrade
|
| Accounts Receivable | 27.12 | 21.18 | 16.65 | 15.91 | 15.93 | Upgrade
|
| Other Receivables | 2.3 | 4.6 | 1.9 | 0.9 | 17.14 | Upgrade
|
| Receivables | 29.42 | 25.78 | 18.55 | 16.81 | 33.07 | Upgrade
|
| Inventory | 6.2 | 9.41 | 4.52 | 7.31 | 7.61 | Upgrade
|
| Prepaid Expenses | 10.39 | 14.74 | 10.13 | 5.82 | 8.14 | Upgrade
|
| Other Current Assets | - | - | 2.99 | - | - | Upgrade
|
| Total Current Assets | 416.7 | 616.78 | 486.44 | 582.83 | 410.41 | Upgrade
|
| Property, Plant & Equipment | 19.63 | 25.54 | 30.05 | 34.3 | 35.09 | Upgrade
|
| Goodwill | 0.75 | 0.75 | 0.75 | 0.94 | 0.94 | Upgrade
|
| Other Intangible Assets | 103.22 | 103.69 | 96.32 | 147.5 | 153.19 | Upgrade
|
| Other Long-Term Assets | 53.82 | 42.16 | 59.03 | 11.07 | 7.81 | Upgrade
|
| Total Assets | 594.13 | 788.91 | 672.59 | 776.63 | 607.44 | Upgrade
|
| Accounts Payable | 23.53 | 41.68 | 17.29 | 15.14 | 12.13 | Upgrade
|
| Accrued Expenses | 86.03 | 107.57 | 95.74 | 75.18 | 56.79 | Upgrade
|
| Current Portion of Long-Term Debt | 68.68 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 5.41 | 4.91 | 4.43 | 3.91 | 0.36 | Upgrade
|
| Current Unearned Revenue | 2.82 | 7.1 | 11.98 | 16.27 | - | Upgrade
|
| Other Current Liabilities | 14.29 | 16.66 | 12.72 | 13.59 | 23.38 | Upgrade
|
| Total Current Liabilities | 200.75 | 177.91 | 142.16 | 124.09 | 92.66 | Upgrade
|
| Long-Term Debt | 310.31 | 377.26 | 375.55 | 226.58 | 215.34 | Upgrade
|
| Long-Term Leases | 17.19 | 22.61 | 27.51 | 31.5 | 28.34 | Upgrade
|
| Long-Term Unearned Revenue | - | 1.84 | 10.93 | 20.38 | - | Upgrade
|
| Other Long-Term Liabilities | 6.8 | 8.49 | 73.59 | 71.98 | 59.89 | Upgrade
|
| Total Liabilities | 535.05 | 588.1 | 629.73 | 474.52 | 396.23 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,506 | 1,328 | 1,060 | 1,069 | 797.99 | Upgrade
|
| Retained Earnings | -1,447 | -1,126 | -1,014 | -765.97 | -585.88 | Upgrade
|
| Comprehensive Income & Other | -0.08 | -1.46 | -2.91 | -0.56 | -0.9 | Upgrade
|
| Shareholders' Equity | 59.08 | 200.81 | 42.85 | 302.11 | 211.21 | Upgrade
|
| Total Liabilities & Equity | 594.13 | 788.91 | 672.59 | 776.63 | 607.44 | Upgrade
|
| Total Debt | 401.58 | 404.78 | 407.49 | 261.99 | 244.03 | Upgrade
|
| Net Cash (Debt) | -30.88 | 162.07 | 42.76 | 290.9 | 117.56 | Upgrade
|
| Net Cash Growth | - | 279.04% | -85.30% | 147.45% | -39.30% | Upgrade
|
| Net Cash Per Share | -0.39 | 2.18 | 0.67 | 4.86 | 2.47 | Upgrade
|
| Filing Date Shares Outstanding | 88.74 | 76.1 | 64.74 | 63.21 | 60.24 | Upgrade
|
| Total Common Shares Outstanding | 87.45 | 75.37 | 64.29 | 62.49 | 52.25 | Upgrade
|
| Working Capital | 215.95 | 438.87 | 344.27 | 458.74 | 317.75 | Upgrade
|
| Book Value Per Share | 0.68 | 2.66 | 0.67 | 4.83 | 4.04 | Upgrade
|
| Tangible Book Value | -44.9 | 96.37 | -54.22 | 153.68 | 57.09 | Upgrade
|
| Tangible Book Value Per Share | -0.51 | 1.28 | -0.84 | 2.46 | 1.09 | Upgrade
|
| Machinery | 4.72 | 5.06 | 4.99 | 4.73 | 2.39 | Upgrade
|
| Construction In Progress | - | 0.17 | 0.08 | 0.63 | 6.34 | Upgrade
|
| Leasehold Improvements | 9.37 | 9.69 | 9.18 | 8.79 | 4.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.